Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03925480Phase 3Completed
Phase 3, randomised, double-blind trial in skin and soft tissue infection (SSTI) comparing Azithromycin with Placebo (2 arms). Primary endpoint: Cumulative incidence of skin and soft tissue infection at 3 months. Started Jul 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03925480.